Technische Daten
Change(s) made:Complete revision
Status:Research Use Only (RUO)
Ig Unterklasse:IgG
Immunogen:Synthetic peptide of human TIM-1
Vorbehandlung:ProTaqs® Antigen Enhancer IV (Cat. No. 401602392)
Zelluläre Lokalisation:Cytoplasmic
Kontrolle:Kidney, renal clear cell carcinoma
Synonyme:AI503787, HAVCR, HAVCR1, HAVCR 1, HA, Vcr-1, hepatitis A virus cellular receptor 1, HKIM-1, Kidney Injury Molecule1, KIM1, KIM 1, KIM-1, TIM-1, TIMD1, TIMD 1, TIMD1, KM-1, TIMD1_HUMAN, T cell immunoglobin domain and mucin domain protein 1, T-cell immunoglobulin and mucin domain-containing protein 1, T-cell membrane protein 1.
Verfügbar in folgenden Ländern:worldwide

T cell immunoglobulin and mucin domain protein 1, also known as TIM1, KIM1, kidney injury molecule 1, HAVcr-1 or Hepatitis A virus cellular receptor 1, is a transmembrane glycoprotein that contributes to immune modulation, allergic response and viral disease susceptibility. It is widely expressed, and localized on the apical membrane. KIM-1 has been extensively evaluated in renal cell carcinoma (RCC) tissues, in lymph nodes to which tumors have metastasized, ovarian clear cell carcinoma and colorectal cancer.